Search alternatives:
significantly greater » significantly correlated (Expand Search), significantly increased (Expand Search), significantly lower (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
significantly greater » significantly correlated (Expand Search), significantly increased (Expand Search), significantly lower (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
-
2081
-
2082
-
2083
-
2084
-
2085
-
2086
-
2087
-
2088
-
2089
-
2090
-
2091
-
2092
-
2093
-
2094
Table 1_Associations between sleep changes and multimorbidity patterns in middle-aged and older Chinese adults.docx
Published 2025“…</p>Results<p>Five multimorbidity patterns were identified: relatively healthy class (55.41%), metabolism class (23.22%), arthritis-digestive class (10.67%), respiratory class (5.42%), multi-system morbidity class (5.28%). Sleep duration decreases of ≥1.0 h were significantly associated with higher odds of overall multimorbidity and specific multimorbidity patterns, particularly metabolism, arthritis-digestive, respiratory, and multi-system morbidity classes (FDR-p < 0.05). …”
-
2095
-
2096
-
2097
-
2098
Study data.
Published 2025“…The Morisky score of the roxadustat group was higher [7 (5, 8) vs. 6 (4, 8), <i>P</i> < 0.01]. The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. …”
-
2099
Summary of clinical outcomes after 9 months.
Published 2025“…The Morisky score of the roxadustat group was higher [7 (5, 8) vs. 6 (4, 8), <i>P</i> < 0.01]. The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. …”
-
2100
Approval by the research ethics committee.
Published 2025“…The Morisky score of the roxadustat group was higher [7 (5, 8) vs. 6 (4, 8), <i>P</i> < 0.01]. The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. …”